Articles
Vol. 37 (2025)
https://doi.org/10.4081/uij.2025.348

Are voiding symptoms associated with the survival outcome of primary female urethral cancer?

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 1 December 2025
245
Views
47
Downloads
Primary female urethral cancer, voiding symptoms, initial presentation, early diagnosis, survival

Authors

Pongsatorn Laksanabunsong
thejae11@gmail.com
Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Kantima Jongjitaree
Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Patkawat Ramart
Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Primary female urethral cancer (PFUC) is a rare urologic malignancy. Some patients who primarily presented with voiding symptoms experienced delayed investigation due to a lack of awareness. Therefore, this retrospective study aimed to compare the clinical information, treatment, and survival outcomes of PFUC between patients who initially presented with voiding symptoms and those with other symptoms. We retrospectively reviewed 13 PFUC patients who were treated at our hospital between January 2010 and December 2023. The overall 2-year survival rate was 55.4%. Factors including high-risk tumor, R1 resection, adenocarcinoma pathology, and nodal metastasis showed statistically significant differences between survival curves. The 2-year survival rates for patients with voiding symptoms and other symptoms were 34.3% and 80%, respectively. Although the overall survival rates between the two groups were not significantly different, PFUC patients with voiding symptoms demonstrated characteristics of advanced disease, including larger tumor size and nodal metastasis.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Swartz MA, Porter MP, Lin DW, Weiss NS. Incidence of primary urethral carcinoma in the United States. Urology 2006;68:1164-8. DOI: https://doi.org/10.1016/j.urology.2006.08.1057
Derksen JW, Visser O, de la Riviere GB, et al. Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol 2013;31:147-53. DOI: https://doi.org/10.1007/s00345-012-0882-5
Champ CE, Hegarty SE, Shen X, et al. Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology 2012;80:374-81. DOI: https://doi.org/10.1016/j.urology.2012.02.058
Kang M, Jeong CW, Kwak C, et al. Survival outcomes and predictive factors for female urethral cancer: long-term experience with Korean patients. J Korean Med Sci 2015;30:1143-9. DOI: https://doi.org/10.3346/jkms.2015.30.8.1143
Dalbagni G, Zhang ZF, Lacombe L, Herr HW. Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy. Br J Urol 1998;82:835-41. DOI: https://doi.org/10.1046/j.1464-410X.1998.00878.x
Garden AS, Zagars GK, Delclos L. Primary carcinoma of the female urethra. Results of radiation therapy. Cancer. 1993;71:3102-8. DOI: https://doi.org/10.1002/1097-0142(19930515)71:10<3102::AID-CNCR2820711034>3.0.CO;2-2
Grigsby PW. Carcinoma of the urethra in women. Int J Radiat Oncol Biol Phys 1998;41:535-41. DOI: https://doi.org/10.1016/S0360-3016(97)00773-6
Lee W, Yu J, Lee JL, et al. Clinical features and oncological outcomes of primary female urethral cancer. J Surg Oncol 2022;125:907-15. DOI: https://doi.org/10.1002/jso.26790
Gakis G, Morgan TM, Efstathiou JA, et al. Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol 2016;34:97-103. DOI: https://doi.org/10.1007/s00345-015-1583-7
Sui W, RoyChoudhury A, Wenske S, et al. Outcomes and prognostic factors of primary urethral cancer. Urology 2017;100:180-6. DOI: https://doi.org/10.1016/j.urology.2016.09.042
Janisch F, Abufaraj M, Fajkovic H, et al. Current disease management of primary urethral carcinoma. Eur Urol Focus 2019;5:722-34. DOI: https://doi.org/10.1016/j.euf.2019.07.001
Gakis G, Morgan TM, Daneshmand S, et al. Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma. Ann Oncol 2015;26:1754-9. DOI: https://doi.org/10.1093/annonc/mdv230
Son CH, Liauw SL, Hasan Y, Solanki AA. Optimizing the role of surgery and radiation therapy in urethral cancer based on histology and disease extent. Int J Radiat Oncol Biol Phys 2018;102:304-13. DOI: https://doi.org/10.1016/j.ijrobp.2018.06.007
Neuville P, Murez T, Savoie PH, et al. Primary urethral carcinoma: Recommendations of the oncology committee of the French Urology Association. Fr J Urol 2024;34:102606. DOI: https://doi.org/10.1016/j.fjurol.2024.102606

How to Cite



Are voiding symptoms associated with the survival outcome of primary female urethral cancer?. (2025). Urogynaecologia, 37. https://doi.org/10.4081/uij.2025.348
Copyright (c) 2025 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.